Surrogate markers for assessing treatment response in HIV disease.
about
Cellular imaging in drug discovery.Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay.beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans.Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay.
P2860
Surrogate markers for assessing treatment response in HIV disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Surrogate markers for assessing treatment response in HIV disease.
@en
type
label
Surrogate markers for assessing treatment response in HIV disease.
@en
prefLabel
Surrogate markers for assessing treatment response in HIV disease.
@en
P2860
P1476
Surrogate markers for assessing treatment response in HIV disease.
@en
P2093
R C Rathbun
P2860
P304
P356
10.1177/106002809302700412
P407
P577
1993-04-01T00:00:00Z